Turtle Cameron
Chief Executive Officer · 25 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 10,176 | $87.44 | $889,789.44 | filing |
| 2026-07-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 4,234 | $88.12 | $373,100.08 | filing |
| 2026-07-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 590 | $88.91 | $52,456.90 | filing |
| 2026-06-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 8,149 | $70.50 | $574,504.50 | filing |
| 2026-06-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 3,557 | $69.40 | $246,855.80 | filing |
| 2026-06-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 3,294 | $71.38 | $235,125.72 | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 5,300 | $69.54 | $368,562.00 | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 3,600 | $70.77 | $254,772.00 | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 3,100 | $73.14 | $226,734.00 | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 1,700 | $74.23 | $126,191.00 | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 1,000 | $71.76 | $71,760.00 | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 300 | $74.96 | $22,488.00 | filing |
| 2026-04-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 12,344 | $49.20 | $607,324.80 | filing |
| 2026-04-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 2,656 | $49.92 | $132,587.52 | filing |
| 2026-03-02 | SYRE | Spyre Therapeutics, Inc. | Sale | 9,100 | $42.49 | $386,659.00 | filing |
| 2026-03-02 | SYRE | Spyre Therapeutics, Inc. | Sale | 5,900 | $41.73 | $246,207.00 | filing |
| 2026-02-02 | SYRE | Spyre Therapeutics, Inc. | Sale | 14,043 | $32.87 | $461,593.41 | filing |
| 2026-02-02 | SYRE | Spyre Therapeutics, Inc. | Sale | 957 | $31.82 | $30,451.74 | filing |
| 2026-01-02 | SYRE | Spyre Therapeutics, Inc. | Sale | 12,709 | $30.47 | $387,243.23 | filing |
| 2026-01-02 | SYRE | Spyre Therapeutics, Inc. | Sale | 2,191 | $31.79 | $69,651.89 | filing |
| 2026-01-02 | SYRE | Spyre Therapeutics, Inc. | Sale | 100 | $32.39 | $3,239.00 | filing |
| 2025-12-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 10,995 | $28.73 | $315,886.35 | filing |
| 2025-12-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 4,005 | $29.83 | $119,469.15 | filing |
| 2025-11-03 | SYRE | Spyre Therapeutics, Inc. | Sale | 28,155 | $23.13 | $651,225.15 | filing |
| 2025-11-03 | SYRE | Spyre Therapeutics, Inc. | Sale | 16,845 | $23.66 | $398,552.70 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.